Page 4 of 5: studies 61 to 80 of 95, newest first. Back to the ayahuasca overview
Human Psychopharmacology: Clinical and Experimental March 17, 2022 Edward James, Joachim Keppler, Thomas L Robertshaw et al.
Data sharing is not applicable to this article as no new data were created or analysed in this study.
Human Psychopharmacology: Clinical and Experimental March 17, 2022 Rafael Lancelotta 2 citations
The author confirms that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.
Research, Society and Development March 16, 2022 Alexandre Machado de Moura, Marcela Barboza de Melo Aragão, Dário César de Oliveira Conceição et al. 2 citations
Objetivo: Investigar evidências terapêuticas da Ayahuasca, que é uma bebida psicoativa obtida da decocção de duas plantas de origem amazônica: Banisteriospsis caapi (cipó Mariri) e Psychotria viridis (Chacrona), comprovadas em estudos clínicos controlados em pacientes com transtornos psiquiátricos. Metodologia: Trata-se de uma revisão integrativa da literatura focada em ensaios clínicos...
Saúde e Desenvolvimento Humano March 7, 2022 Maria Eduarda Kegler Ramos, João Pedro Popilniski Strapasson, Cassiano Mateus Forcelini et al. 1 citation
Introdução: As vicissitudes da vida moderna, as instabilidades sociais, econômicas e comportamentais tem feito com que o consumo de chás, medicamentos, drogas e álcool tenha aumentado como alternativa de fuga dos problemas do dia-a-dia. Nos últimos anos, alguns estudos mostraram um potencial ansiolítico e antidepressivo do chá de Ayahuasca, baseado em relatos de adeptos de seitas religiosas que...
Psychopharmacology March 7, 2022 Yasmim A. Serra, Thaísa Barros-Santos, Alexia Anjos-Santos et al. 28 citations
Treatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD.
Journal of Psychopharmacology March 1, 2022 Gabrielle Agin-Liebes, Richard J. Zeifman, Jason B. Luoma et al. 51 citations
Background: Evidence suggests that psychedelic-assisted therapy carries transdiagnostic efficacy in the treatment of mental health conditions characterized by low mood and the use of avoidance coping strategies. Aims: While preliminary evidence suggests that psychological flexibility and emotion regulation processes play an important role within psychedelic therapy, this prospective study...
Journal of Psychopharmacology March 1, 2022 Max Wolff, Lea J. Mertens, Marie Walter et al. 57 citations
Background: Many benefits and some harms associated with psychedelic use could be attributable to these drugs’ acceptance/avoidance-promoting effects and corresponding changes in psychological flexibility. Underlying psychological mechanisms are insufficiently understood. Aim: The purpose of this study was the validation of a psychological model of acceptance/avoidance-promoting psychedelic...
Journal of the Royal Anthropological Institute February 24, 2022 Alex K. Gearin 12 citations
Abstract Analysing healing practices at an ayahuasca tourism centre in Peru, this article illustrates how Shipibo practices of curing and sorcery have adapted to the demands of international clients searching for primitivist healing experiences. At the core of this adaption is the thorny issue of occult power and its relation to capital accumulation. Sorcery here does not serve clients but is...
Journal of Clinical Medicine February 21, 2022 Ľuboš Nižňanský, Žofia Nižnanská, Roman Kuruc et al. 11 citations
Ahyahuasca is a term commonly used to describe a decoction prepared by cooking the bark or crushed stems of the liana Banisteriopsis caapi (contains β-carbolines) alone or in combination with other plants, most commonly leaves of the shrub Psychotria viridis (contains N,N-dimethyltryptamine-DMT). More than 100 different plants can serve as sources of β-carbolines and DMT, which are the active...
Psychopharmacology February 18, 2022 Dimitri Daldegan-Bueno, Lucas Oliveira Maia, Carolina Marcolino Massarentti et al.
RationaleSmoking-related disease is a major problem globally. Effective smoking cessation treatments are however limited. Increasing evidence suggests that psychedelics have potential as treatments for substance use disorders and may therefore prove an option in aiding smoking cessation.ObjectivesTo establish which factors predict smoking cessation in people who reported quitting or reducing...
Human Psychopharmacology: Clinical and Experimental February 17, 2022 Edward James, Joachim Keppler, Ben Sessa et al. 41 citations
Abstract Objective Reports have indicated possible uses of ayahuasca for the treatment of conditions including depression, addictions, post‐traumatic stress disorder, anxiety and specific psychoneuroendocrine immune system pathologies. The article assesses potential ayahuasca and N,N‐dimethyltryptamine (DMT) integration with contemporary healthcare. The review also seeks to provide a summary of...
February 14, 2022 Daniel Perkins, Simon Ruffell, Kimberley Day et al. 1 citation preprint
Ayahuasca is a psychoactive Amazonian plant brew. It is usually made from the Banisteriopsis caapi vine, which contains three primary harmala alkaloids, along with the leaves of Psychotria viridis in which the potent psychedelic dimethyltryptamine (DMT) is found. DMT-harmaloid concoctions have gained popularity in recent years, due to growing anecdotal and scientific reports of therapeutic...
Human Psychopharmacology: Clinical and Experimental February 2, 2022 Rafael G. Dos Santos, Juliana Mendes Rocha, Giordano Novak Rossi et al. 20 citations
Abstract Objective To assess endocannabinoid (anandamide, AEA; 2‐arachidonoylglycerol, 2‐AG) plasma levels in healthy volunteers and in volunteers with social anxiety disorder (SAD) after a single oral dose of ayahuasca or placebo. Methods Post hoc analysis of endocannabinoid plasma levels (baseline, 90 and 240 min after drug intake) from two parallel‐group, randomized, placebo‐controlled...
Psychopharmacology January 24, 2022 Kim van Oorsouw, S. W. Toennes, J. G. Ramaekers 71 citations
RATIONALE: Studies have suggested mental health improvements following the use of the psychotropic plant concoction ayahuasca in non-clinical and clinical samples. OBJECTIVES: The present observational study assessed depressive symptomatology in 20 clinically depressed patients (symptom score > 13 on the Beck's Depression Inventory) before attendance of an ayahuasca ceremony and 1 month and 1...
Transcultural Psychiatry January 6, 2022 Eduardo Ekman Schenberg, Konstantin Gerber 18 citations
After decades of biomedical research on ayahuasca's molecular compounds and their physiological effects, recent clinical trials show evidence of therapeutic potential for depression. However, indigenous peoples have been using ayahuasca therapeutically for a very long time, and thus we question the epistemic authority attributed to scientific studies, proposing that epistemic injustices were...
Entre trópicos 2022 Mauricio Guzmán, Beatriz C. Labate
Este capítulo apresenta a reflexão sobre os contatos e intercâmbios entre usuários de ayahuasca e de peiote em contextos rituais no México. Diferentemente do que opinam outros autores, os contatos e usos alternados ou combinados dessas substâncias enteógenas não acontecem de forma descontextualizada, constante ou desterritorializada. Essas novas formas revelam negociações ou acordos...
Journal de la Société des Américanistes 2022 Doriane Slaghenauffi 2 citations
L’émergence du « tourisme chamanique » dans certaines zones urbaines et dans des villages shipibo-konibo est à l’origine d’une recrudescence des pratiques sorcellaires vernaculaires, désormais intégrées au nouveau contexte sociologique de commercialisation du chamanisme végétaliste local. Ces attaques occultes visent non seulement des praticiens rivaux mais aussi des touristes en quête d’une...
ABSTRACT BOOK 2022 2022
Objetivos: Caso altamente probable de Psicosis inducida por Ayahuasca en nuestro país. Material y Métodos: Caso clínico atendido en Unidad de Hospitalización de adultos. Resultados y conclusiones: Mujer de 51 años de edad, natural de la provincia de Zaragoza. Casada hace 25 años, dos hijos de 21 y 24. Peluquera en un pueblo de la misma provincia. Círculo social adecuado. Sin antecedentes de...
ABSTRACT BOOK 2022 2022
La ayahuasca es una bebida psicoactiva compuesta por dos plantas que tienen su crecimiento en la selva amazónica (Banisteriopssis caapi o yagé y Psychotria viridis o chacruna).Esta última contiene el principio psicoactivo DMT, causante de intensas alucinaciones. Se presenta el caso de un varón de 33 años de nacionalidad británica que acude al servicio de urgencias psiquiátricas por alteraciones...
Current Topics in Behavioral Neurosciences 2022 Fernanda Palhano-Fontes, Bruno Lobão‐soares, Nicole Leite Galvão‐coelho et al. 25 citations
Ayahuasca, the vine of the souls in Quechua, is a psychedelic brew with a few formulations that most often include the bark of a liana in the Malpighiaceae family (Banisteriopsis caapi), with leaves from a shrub in the coffee family Rubiaceae (Psychotria viridis). Mixed with water and boiled for hours or days, it produces a brownish-colored liquid with a strong and characteristic taste....